By Nate Raymond BOSTON (Reuters) - A medical device company has agreed to pay $42 million and plead guilty to resolve U.S. charges that it concealed a .
Magellan Diagnostics admits that it misled customers and the FDA about a device malfunction that produced inaccurately low results in lead level blood tests for potentially tens of thousands of children and other patients.
Update Magellan Diagnostics to pay $42M to settle lead case bostonglobe.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from bostonglobe.com Daily Mail and Mail on Sunday newspapers.
Medical device company to pay $42 million to resolve US lead-testing defect charges yahoo.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from yahoo.com Daily Mail and Mail on Sunday newspapers.
BOSTON — A medical device company headquartered in Billerica, Mass., has agreed to pay $42 million and plead guilty to resolve charges that it concealed a malfunction in its lead-testing
DOJ: Former Magellan quality control director, execs misled public over lead tests complianceweek.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from complianceweek.com Daily Mail and Mail on Sunday newspapers.
DOJ: Magellan quality control director, execs misled public about flawed lead tests complianceweek.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from complianceweek.com Daily Mail and Mail on Sunday newspapers.
BOSTON — Three former executives of a Billerica-based medical device company are facing federal charges for allegedly concealing flaws in a lead-testing system that authorities say produced inaccurate results for
BILLERICA Three former executives of Magellan Diagnostics are facing federal fraud charges in connection with the alleged concealment of malfunctions in lead testing devices that showed inaccurately lower lead levels in the blood of what is estimated to be tens of thousands of children and other patients.
The problems at Magellan Diagnostics in North Billerica first became public in 2017 when the Food and Drug Administration warned Americans that the company was actually having serious issues with some of its devices returning false results.